Kukje Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10,703	8,678	10,590	5,539	7,866
Trading Asset Securities	20.34	76.49	42.29	20.18	36.91
Cash & Short-Term Investments	10,724	8,755	10,632	5,559	7,903
Cash Growth	22.49%	-17.66%	91.26%	-29.66%	84.93%
Accounts Receivable	23,978	22,761	20,429	19,131	20,653
Other Receivables	4,552	741.8	708.07	1,222	2,819
Receivables	29,845	24,656	22,141	20,359	23,486
Inventory	25,850	22,369	21,243	22,235	16,540
Prepaid Expenses	25.64	28.94	35.34	35.21	23.51
Other Current Assets	933.2	1,165	1,067	347.29	244.12
Total Current Assets	67,377	56,974	55,119	48,535	48,197
Property, Plant & Equipment	98,443	98,185	99,124	78,380	81,981
Long-Term Investments	8,772	4,545	3,195	3,984	3,953
Other Intangible Assets	1,386	870.1	919.29	944.49	935.19
Long-Term Deferred Charges	0	0	0	180.95	398.08
Other Long-Term Assets	6,298	4,824	4,902	4,569	4,319
Total Assets	182,276	165,548	163,259	136,593	139,783
Accounts Payable	15,834	11,064	8,564	7,068	7,249
Accrued Expenses	1,034	893.87	918.01	1,235	1,110
Short-Term Debt	3,000	2,000	30,000	27,000	32,000
Current Portion of Long-Term Debt	27,000	-	-	-	2,000
Current Portion of Leases	110.2	169.69	186.34	399.95	366.36
Current Income Taxes Payable	986.15	1,372	1,566	1,488	302.48
Other Current Liabilities	14,055	13,047	18,453	10,664	11,489
Total Current Liabilities	62,020	28,547	59,687	47,855	54,517
Long-Term Debt	-	27,000	-	-	-
Long-Term Leases	293.79	341.94	475.74	1,196	1,620
Pension & Post-Retirement Benefits	-	1,824	-	1,244	5,272
Long-Term Deferred Tax Liabilities	13,265	12,724	13,054	7,895	7,248
Other Long-Term Liabilities	8,995	5,562	5,092	4,323	2,538
Total Liabilities	84,574	75,999	78,310	62,514	71,195
Common Stock	21,160	21,160	21,160	20,195	19,276
Additional Paid-In Capital	3,359	2,360	2,094	3,059	3,978
Retained Earnings	10,661	5,406	-3,391	6,327	1,095
Treasury Stock	-	-2,253	-2,566	-2,535	-2,494
Comprehensive Income & Other	62,509	62,868	67,647	47,028	46,714
Total Common Equity	97,689	89,542	84,944	74,074	68,568
Minority Interest	13.64	6.39	5.49	5.19	19.75
Shareholders' Equity	97,702	89,548	84,950	74,079	68,588
Total Liabilities & Equity	182,276	165,548	163,259	136,593	139,783
Total Debt	30,404	29,512	30,662	28,596	35,987
Net Cash (Debt)	-19,680	-20,757	-20,030	-23,037	-28,084
Net Cash Per Share	-967.15	-1020.85	-988.96	-1137.06	-1385.71
Filing Date Shares Outstanding	20.31	20.36	20.25	20.26	20.27
Total Common Shares Outstanding	20.31	20.36	20.25	20.26	20.27
Working Capital	5,358	28,427	-4,568	680.31	-6,319
Book Value Per Share	4810.44	4397.39	4194.43	3656.47	3383.53
Tangible Book Value	96,302	88,672	84,025	73,130	67,633
Tangible Book Value Per Share	4742.18	4354.66	4149.04	3609.85	3337.38
Land	72,064	72,064	72,736	46,629	46,808
Buildings	23,270	25,051	25,563	26,478	26,804
Machinery	48,110	50,847	39,015	40,488	41,862
Construction In Progress	2,307	349.3	91.5	123	151.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.